Wedbush Adjusts Bluebird Bio's Price Target to $1.68 From $3, Maintains Neutral Rating
Wedbush Adjusts Bluebird Bio's Price Target to $1.68 From $3, Maintains Neutral Rating
Wedbush将蓝鸟生物的目标股价从3美元调整至1.68美元，维持中性评级
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册